Ticker Symbol: PULM
Pulmatrix Inc
$0.78 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001574235
Company Profile
Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology. The Company's proprietary product pipeline includes treatments for serious lung diseases such as allergic bronchopulmonary aspergillosis ('ABPA') and lung cancer, as well as neurologic disorders such as acute migraine. Pulmatrix's product candidates are based on iSPERSE™, its proprietary engineered dry powder delivery platform, which seeks to improve therapeutic delivery to the lungs by maximizing local concentrations and reducing systemic side effects to improve patient outcomes.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 99 Hayden Ave Ste 390
Website: pulmatrix.com
CEO: Teofilo Raad
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $2.03
Change:
$0.00
(
-0.35%)
Days Range: $1.98 - $2.04
Beta: 0.49
52wk. High: $4.49
52wk. Low: $1.87
Ytd. Change -47.78%
50 Day Moving Average: $2.10
200 Day Moving Average: $2.56
Shares Outstanding: 3652285
Valuation
Market Cap: 742.4M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A